Fructose-contained astragalus oral liquid

A technology of astragalus oral liquid and fructose, which is applied in the directions of drug delivery, plant raw materials, metabolic diseases, etc., can solve the problems of high sweetness, low calorific value, and restriction of fructose, and achieve the effect of enhancing drug efficacy and good immune function.

Inactive Publication Date: 2010-12-22
沈颂华
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, domestic therapeutic infusions are composed of glucose or sodium chloride plus drugs, which are greatly limited in the trea...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Embodiment 1 prepares fructose Huangqi oral liquid

[0015] Fructose 10g

[0016] Astragalus Extract (Astragaloside IV Polysaccharide) 40g

[0017] Propylene glycol 1g

[0018] Purified water 100ml

[0019] Preparation:

[0020] 1) preparing an extract of Astragalus membranaceus, the main component of which is astragaloside IV polysaccharide.

[0021] a. Astragalus raw material is submerged in water, heated and refluxed for extraction, and the extract is concentrated to a thick extract;

[0022] b. Add ethanol to the thick extract for ethanol precipitation. After recovering the ethanol from the supernatant, add an alkaline solution to adjust the pH value to ≥ 7, and hydrolyze at 60-120°C for 0.5-3h;

[0023] c. The hydrolyzate is sterilized by high temperature, baked and filtered, and the precipitate is washed with an alkali solution until it is colorless, and then washed with water until it is neutral;

[0024] d. extract astragaloside polysaccharide by negative ...

Embodiment 2

[0027] Embodiment 2 prepares fructose Huangqi oral liquid

[0028] Fructose 5g

[0029] Astragalus Extract (Astragaloside IV Polysaccharide) 30g

[0030] Propylene glycol 1g

[0031] Purified water 100ml

[0032] Preparation method: prepare fructose astragalus oral liquid

[0033] 1) preparing an extract of Astragalus membranaceus, the main component of which is astragaloside IV polysaccharide.

[0034] a. Astragalus raw materials are submerged in water, heated and refluxed for extraction, and the extract is concentrated to a thick extract;

[0035] b. Add ethanol to the thick extract for ethanol precipitation. After recovering the ethanol from the supernatant, add an alkaline solution to adjust the pH value to ≥ 7, and hydrolyze at 60-120°C for 0.5-3h;

[0036] c. The hydrolyzate is sterilized by high temperature, baked and filtered, and the precipitate is washed with an alkali solution until it is colorless, and then washed with water until it is neutral;

[0037] d. e...

Embodiment 3

[0040] Embodiment 3 prepares fructose Huangqi oral liquid

[0041] Fructose 8g

[0042] Astragalus Extract (Astragaloside IV Polysaccharide) 35g

[0043] Propylene glycol 1.5g

[0044] Purified water 100ml

[0045] Preparation method: prepare fructose astragalus oral liquid

[0046] 1) preparing an extract of Astragalus membranaceus, the main component of which is astragaloside IV polysaccharide.

[0047] a. Astragalus raw materials are submerged in water, heated and refluxed for extraction, and the extract is concentrated to a thick extract;

[0048] b. Add ethanol to the thick extract for ethanol precipitation. After recovering the ethanol from the supernatant, add an alkaline solution to adjust the pH value to ≥ 7, and hydrolyze at 60-120°C for 0.5-3h;

[0049] c. The hydrolyzate is sterilized by high temperature, baked and filtered, and the precipitate is washed with an alkali solution until it is colorless, and then washed with water until it is neutral;

[0050] d....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to fructose-contained astragalus oral liquid which is prepared from the following raw materials in parts by weight: 5-10 parts of fructose, 30-40 parts of astragalus extract, 1-1.5 part of stabilizer and 100 parts of purified water. By adding the extract liquid of traditional Chinese medicine astragalus, the fructose-contained astragalus oral liquid enhances the drug effects and has favorable auxiliary treatment effect on patients with decreased immune functions due to diabetes or after burn and scald operations.

Description

technical field [0001] The invention relates to a fructose oral liquid containing fructose and astragalus. Background technique [0002] Under normal circumstances, the glucose (blood sugar) content of human blood is relatively constant. For patients who are in a state of insulin resistance such as burns and post-operative infections, and need to replenish water or energy, oral glucose liquid is used for body fluid supplementation therapy. Supplementation of water and energy is not appropriate. At present, domestic therapeutic infusions are composed of glucose or sodium chloride plus drugs, which are greatly limited in the treatment of diseases in patients who are forbidden to eat sugar or salt. [0003] Fructose has high sweetness, fruity aroma and low calorific value. Diabetics have a better tolerance to fructose than sucrose and glucose. Therefore, fructose is used as a sweetener for special foods, especially for diabetics and obese patients. Contents of the invention...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/481A61K9/08A61P3/10A61P17/02A61K31/7004A61K125/00
Inventor 沈颂华
Owner 沈颂华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap